Document Detail


CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.
MedLine Citation:
PMID:  18645269     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: The CDKN1B (p27) V109G polymorphism has been suggested to confer the risk of advanced prostate cancer in Caucasian males. However, its prevalence in Asian populations has never been reported. The aim of this study was to determine the CDKN1B V109G polymorphism frequency in the low incidence Taiwanese population and investigate its potential role on prostate cancer susceptibility and disease progression. METHODS: A hospital-based case-control study was conducted, which enrolled a total of 190 prostate cancer patients and 292 age-matched male controls. PCR-RFLP was used to determine the CDKN1B V109G polymorphism. The association between CDKN1B V109G and prostate cancer risk and clinicopathologic variables was analyzed. RESULTS: The variant CDKN1B G allele frequency in Taiwanese males appears to be low (2.1%). Overall, there was no significant association between CDKN1B V109G polymorphism and prostate cancer risk. Similarly, no significant findings were found when further stratified by different age groups, disease stages, and pathological grades. In terms of disease outcome, the CDKN1B V109G genotypes were not associated with either hormone response status after hormone therapy (p = 0.730) or with prostate-specific antigen recurrence for clinically localized prostate cancer patients who receive radical prostatectomy (p = 0.536). CONCLUSIONS: There was a low prevalence of CDKN1B V109G polymorphism in Taiwanese compared to Caucasian males. Hence, it may not be an appropriate biomarker of prostate cancer among the Taiwanese population. Further large-scale studies are needed to clarify the role of CDKN1B V109G polymorphism on prostate cancer risk.
Authors:
Shu-Pin Huang; Chia-Cheng Yu; Chia-Chu Liu; Tony T Wu; Chun-Hsiung Huang; Ming-Tsang Wu
Related Documents :
17382509 - Capn10 alleles modify laryngeal cancer risk in the spanish population.
18483329 - Effect modification by catalase genotype suggests a role for oxidative stress in the as...
18676749 - Genetic polymorphisms of metastasis suppressor gene nme1 and breast cancer survival.
15978329 - Stromal cell-derived factor-1 (sdf-1) alleles and susceptibility to breast carcinoma.
16077979 - Genetic susceptibility of catechol-o-methyltransferase polymorphism in japanese patient...
17671399 - Investigation of vascular endothelial growth factor gene polymorphisms and its associat...
9020289 - Radiation therapy for squamous cell carcinoma in dystrophic epidermolysis bullosa: case...
18158069 - Oncolytic virotherapy for prostate cancer by e1a, e1b mutant adenovirus.
19900979 - Squamous cell carcinoma arising in a recent plaque of discoid lupus erythematous, in a ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-07-16
Journal Detail:
Title:  Urologia internationalis     Volume:  81     ISSN:  1423-0399     ISO Abbreviation:  Urol. Int.     Publication Date:  2008  
Date Detail:
Created Date:  2008-07-22     Completed Date:  2008-12-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417373     Medline TA:  Urol Int     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  36-40     Citation Subset:  IM    
Copyright Information:
(c) 2008 S. Karger AG, Basel.
Affiliation:
Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Case-Control Studies
Cell Cycle
Disease Progression
Humans
Intracellular Signaling Peptides and Proteins / genetics*,  physiology
Male
Middle Aged
Polymerase Chain Reaction
Polymorphism, Genetic*
Polymorphism, Restriction Fragment Length
Prostatic Neoplasms / diagnosis*,  genetics*
Risk
Taiwan
Tumor Markers, Biological
Chemical
Reg. No./Substance:
0/CDKN1B protein, human; 0/Intracellular Signaling Peptides and Proteins; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is there any clinical parameter able to predict prostate cancer after initial diagnosis of atypical ...
Next Document:  Endoscopic treatment of vesicoureteral reflux in children: our experience and analysis of factors af...